Compounds > parthenolide

parthenolide and Migraine Disorders

parthenolide has been researched along with Migraine Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greco, R; Morazzoni, P; Nappi, G; Riva, A; Sandrini, G; Tassorelli, C1
Carty, HC1
Bolay, H; Chiarugi, A; Moskowitz, MA; Reuter, U1

Other Studies

3 other study(ies) available for parthenolide and Migraine Disorders

ArticleYear
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.
    Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Immunohistochemistry; Male; Migraine Disorders; Neurons; NF-kappa B; Nitroglycerin; Oncogene Proteins v-fos; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Vasodilator Agents

2005
Herbal preparations under scientific scrutiny.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Nov-01, Volume: 155, Issue:9

    Topics: Canada; Drug Approval; Humans; Migraine Disorders; Phytotherapy; Sesquiterpenes

1996
Nuclear factor-kappaB as a molecular target for migraine therapy.
    Annals of neurology, 2002, Volume: 51, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents

2002